# Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin

> **NCT00785980** · PHASE1 · COMPLETED · sponsor: **Mutual Pharmaceutical Company, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Quinine Sulfate Capsules 324 mg
- **DRUG:** Ciprofloxacin 500 mg
- **DRUG:** Quinine Sulfate Capsules 324 mg

## Key facts

- **NCT ID:** NCT00785980
- **Lead sponsor:** Mutual Pharmaceutical Company, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2012-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00785980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00785980, "Drug - Drug Interaction Study of Quinine Sulfate and Ciprofloxacin". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00785980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
